Citeline And Norstella Merge To Provide End-To-End Solutions For Pharma
Marriage Of Commercial And Clinical Capabilities
Publisher’s Spotlight: Citeline, the publisher of In Vivo, is to merge with fellow pharmaceutical solutions provider Norstella.
You may also be interested in...
Publisher’s Spotlight: Leading global growth investor Warburg Pincus has acquired Informa’s Pharma Intelligence unit, the publisher of Scrip.
On this podcast, In Vivo's Jo Shorthouse is joined by Rebekah Martin, senior vice president of reward, inclusion, and talent acquisition at AstraZeneca to talk about the ways that pharma should be encouraging a diverse and inclusive team of young talent, and that strong connection between diversity of thought and innovation.
Leading the company with the only therapy approved for NTM lung disease, Will Lewis tells In Vivo that success comes from giving researchers room to breath, visualizing patient benefit, and sailing into uncharted waters.